Inventor
LIN EDWARD YIN-SHIANG
US30 patents
⚠️ This page may combine multiple inventors who share the name “LIN EDWARD YIN-SHIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN MA INC
19 patentsUS9186367B2Nov 17, 2015
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC15 citations91
US10166250B2Jan 1, 2019
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC9 citations84
US9827258B2Nov 28, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC8 citations84
US9572824B2Feb 21, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC10 citations84
US10034869B2Jul 31, 2018
S1P modulating agents
BIOGEN MA INC2 citations73
US9850206B2Dec 26, 2017
S1P and/or ATX modulating agents
BIOGEN MA INC4 citations73
US9808449B2Nov 7, 2017
S1P modulating agents
BIOGEN MA INC2 citations73
US10894040B2Jan 19, 2021
S1P modulating agents
BIOGEN MA INC0 citations62
US12275728B2Apr 15, 2025
O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
BIOGEN MA INC0 citations60
US12180205B2Dec 31, 2024
O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
BIOGEN MA INC0 citations60
US10406144B2Sep 10, 2019
SIP modulating agents
BIOGEN MA INC0 citations52
US10081646B2Sep 25, 2018
Heterobicyclic sphingosine 1-phosphate analogs
BIOGEN MA INC0 citations52
US9708353B2Jul 18, 2017
Heterobicyclic sphingosine 1-phosphate analogs
BIOGEN MA INC0 citations52
US12522595B2Jan 13, 2026
Bicyclic ether O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
BIOGEN MA INC0 citations50
US12421224B2Sep 23, 2025
Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
BIOGEN MA INC0 citations50
US12319679B2Jun 3, 2025
Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
BIOGEN MA INC0 citations50
US11459324B2Oct 4, 2022
O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors
BIOGEN MA INC0 citations50
US11465963B2Oct 11, 2022
Tetrahydronaphthalene derivatives useful as Nrf2 activators
BIOGEN MA INC0 citations44
US10968181B2Apr 6, 2021
NRF2 activator
BIOGEN MA INC0 citations44